Naitive Technologies Ltd

Company profile

About Naitive Technologies Ltd

Naitive Technologies is a health AI company dedicated to transforming musculoskeletal care through intelligent, pathway-driven technologies. The company's mission is to ensure every high-risk patient is identified early, treated appropriately, and supported throughout their care journey. Naitive's flagship product, OsteoSight, is an FDA-cleared AI platform that performs opportunistic bone health assessment by analyzing X-rays in the background to identify patients with poor bone mineral density. The technology addresses a critical gap in orthopedic care: 90% of orthopedic patients with poor bone health are not captured due to lack of effective screening, representing $170,000 per surgeon per year in lost downstream reimbursement opportunity. The platform uses a proprietary image processing pipeline that segments bone and isolates regions most predictive of low bone mineral density, enabling transparent and reproducible results. Beyond patient identification, Naitive is building a comprehensive bone health care pathway that includes tools to convert patients from referral to treatment (boosting conversion by 20%) and coordinate patient care while minimizing administrative time. The company works with leading orthopedic facilities in the United States and collaborates with major research institutions to validate their technology. Naitive serves orthopedic providers, health systems, and surgical practices, helping them expand bone health services, capture ancillary revenue, and improve patient outcomes through earlier intervention.

Company description · Naitive Technologies Ltd official website